Background illustration for clinical trials search

Paid Clinical Trials St. Petersburg

Discover 1,443 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

for
Geographic Atrophy
Location: St. Petersburg FL, Durham NC, Nashville TN,
Sponsor: Genentech, Inc.

Sex: All

Age: 50+

Code: NCT05626114

Phase2, Recruiting
FeaturedActive & Responsive

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Location: St. Petersburg FL, Delray Beach FL, Tamarac FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07165028

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

for
Rheumatoid Arthritis
Location: Clearwater FL, Tampa FL, Avon Park FL, Orlando FL,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06972446

Phase2, Recruiting
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Clearwater FL, Tampa FL, Lakewood Rch FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

for
Moderately to Severely Active Ulcerative Colitis
Location: Tampa FL, Orlando FL, Fuquay-Varina NC, Port Orange FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06588855

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
FeaturedActive & Responsive

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

for
Metastatic Colorectal Cancer
Location: Tampa FL, Jacksonville FL, Baton Rouge LA, Nashville TN,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT04929223

Phase1, Recruiting
Featured

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

for
Non-Small Cell Lung Cancer
Location: St. Petersburg FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05789082

Phase1, Phase2, Recruiting
Featured

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer
Location: St. Petersburg FL, Ocala FL, West Palm Beach FL,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06568939

Phase2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

for
Ovarian Cancer
Location: St. Petersburg FL, Orlando FL, Gainesville FL,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07059845

Phase2, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: St. Petersburg FL, Fort Myers FL, Gainesville FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06793215

Phase3, Recruiting
Featured

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: St. Petersburg FL, Clearwater FL, Port Orange FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351058

Phase3, Recruiting
Featured

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

for
Diabetic Macular Edema
Location: St. Petersburg FL, Germantown TN, Lynchburg VA,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07425522

Phase1, Recruiting
FeaturedNew

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for
Crohn's Disease, Ulcerative Colitis
Location: Largo FL, Bradenton FL, New Port Richey FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase2, Recruiting
Featured

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

for
Alzheimers Disease
Location: Tampa FL, Clermont FL, The Villages FL, Lady Lake FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07177352

Phase3, Recruiting
Featured

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for
Crohn's Disease
Location: Tampa FL, New Port Richey FL, Zephyrhills FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase2, Recruiting
FeaturedNew

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Clearwater FL, The Villages FL, Orlando FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase2, Recruiting
Featured

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

for
Systemic Lupus Erythematosus, Rheumatoid Arthritis
Location: Clearwater FL, Tampa FL, Kissimmee FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07607964

Phase1, Recruiting
Featured

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

for
Atopic Dermatitis
Location: Tampa FL, Alpharetta GA, Camp Hill PA, Troy MI, London,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07223697

Phase2, Recruiting
Featured

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Tampa FL, Lakeland FL, Lehigh Acres FL, Orlando FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819891

Phase3, Recruiting
Featured

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

for
Hemophilia A
Location: Tampa FL, Indianapolis IN, Iowa City IA, Aurora CO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 12+

Code: NCT07416604

Phase3, Recruiting